ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Aster DM Quality Care issued an addendum to its 18th AGM notice, providing additional information regarding the proposed capital allocation framework for shareholders.
ICRA upgraded KIMS Healthcare Management's long-term rating to AA (Stable) from AA-, removing it from Rating Watch. The upgrade reflects stronger parent support post-Aster-QCIL merger.
Catalyst Trusteeship released a pledge and created a new hold on Aster DM Quality Care shares. The encumbrance secures term loan facilities from Barclays and JPMorgan.
UMHL released a pledge and created a non-disposal undertaking over 2.49 Cr shares securing USD 210 million. The encumbrance backs UIPL's Barclays-JPMorgan loan facilities.
Aster DM announced KIMSHEALTH New Block adding ~184 beds by May 2028 at a cost of ₹134.4 Crore. The expansion addresses space constraints in Trivandrum.
Aster DM Quality Care has submitted its Integrated Annual Report for FY 2025-26 and the notice for its 18th Annual General Meeting scheduled for September 28, 2026.
Aster DM Quality Care Ltd announced its 18th Annual General Meeting scheduled for September 28, 2026, and submitted the Integrated Annual Report for FY 2025-26.
The promoter Moopen family acquired a 0.57% additional stake in Aster DM Quality Care for Rs.350.34 Crore. This increases their total shareholding to approximately 24.58%.
Promoter group entity Union (Mauritius) Holdings Limited acquired 49,96,077 shares worth ₹419.58 Crore via open market purchases.
Aster DM Quality Care Ltd reported its first results as a unified entity following the merger with Quality Care. Management highlights strong momentum driven by high-acuity care and operational synergies across 39 hospitals.
Aster DM Quality Care reports strong Q1 FY27 results following a landmark merger, focusing on scale and clinical synergies across India.
Aster DM Quality Care Q1 FY27 highlights the merger of Aster and Quality Care, reporting combined proforma revenue of INR 2,597 Cr and robust EBITDA margins.
Aster DM Quality Care Ltd reported revenue from operations of ₹1,311 Cr (+21.6% YoY) and net profit of ₹29.3 Cr (-68.7% YoY) for Q1 FY27.
Aster DM Healthcare announced a major merger with Blackstone-backed Quality Care (QCIL) to create a top-3 Indian hospital chain with 10,623 beds and ₹9,273 Cr proforma revenue.
Aster DM Healthcare reported strong Q4 FY26 performance with proforma revenue growing 18% YoY and EBITDA 25%, driven by volume growth and margin expansion ahead of its merger with Quality Care.
Aster DM delivered 18% YoY revenue growth in Q4FY26 reaching ₹1,182 Cr. Post-merger with QCIL, the combined proforma revenue hit ₹2,361 Cr with a focus on bed capacity expansion and operational efficiencies.
Aster DM Healthcare reported Q4FY26 revenue of ₹1,182 Cr (up 18%) and Operating EBITDA of ₹244 Cr (up 26%). Strategy focuses on merger with QCIL and major bed capacity expansion.
Aster DM Quality Care Ltd reported revenue from operations of ₹1,182 Cr (+18.2% YoY) and net profit of ₹153.6 Cr (+79.6% YoY) for Q4 FY26.